Enanta Pharmaceuticals, Inc.
ENTANASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $349.08M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $10.20$17.15
- Volume (live)
- -
- Avg. volume (3M)
- 266.93K
Enanta Pharmaceuticals (ENTA) Stock Price & Financial Analysis
Enanta Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $11.65 - $12.06 |
|---|---|
| 52-Week High | $17.15 |
| 52-Week Low | $10.20 |
| Open | $11.73 |
| Volume (last close) | 440.62K |
| Average Volume (3M) | 266.93K |
| Revenue (TTM) | 65.26M |
|---|---|
| Net Income (TTM) | -63.23M |
| Free Cash Flow (TTM) | -36.94M |
| EPS (TTM) | −$2.34 |
| Profit Margin | -96.89% |
| Operating Margin | -89.99% |
| Return on Equity (ROE) | -62.56% |
| Debt to Equity | 0.55 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 349.08M |
|---|---|
| Shares Outstanding | 29.09M |
| Price to Sales (P/S) | 5.35 |
| Price to Book (P/B) | 3.45 |
| EV/EBITDA | -7.60 |
| 50-Day MA | $12.82 |
|---|---|
| 200-Day MA | $13.27 |
| 1-Year Change | +8.90% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Enanta Pharmaceuticals at a Glance
As of the Oct 26, 2026 close, Enanta Pharmaceuticals (ENTA) has a market capitalization of $349.08M. The stock trades at 5.3× sales. Over the trailing twelve months it lost $63.23M on revenue of $65.26M and burned $36.94M of free cash flow. Revenue grew 0.7% year over year.
As of its latest reported balance sheet, it holds $33.42M in cash and securities against $55.66M of debt, a net debt position of $22.24M.
Enanta Pharmaceuticals does not currently pay a dividend.
The share price is up 8.9% over the past year. At $12.00 (the Oct 26, 2026 close) it sits within its 52-week range of $10.20 to $17.15, below its 200-day moving average of $13.27.
Based on 1 professional analyst rating from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Enanta Pharmaceuticals
What is the current stock price for ENTA?
As of the Oct 26, 2026 close, ENTA stock trades at $12.00. The 52-week range is $10.20–$17.15, with a day range of $11.65–$12.06.
What is the P/E ratio for ENTA?
The P/E ratio (Price-to-Earnings) for ENTA is shown in the Key Statistics section. This valuation metric helps compare Enanta Pharmaceuticals, Inc. to industry peers.
Does ENTA pay dividends?
Enanta Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENTA?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for ENTA is Hold.
What is the market cap of ENTA?
As of the Oct 26, 2026 close, Enanta Pharmaceuticals's market capitalization is $349.1M, classifying it as a small-cap company. Enanta Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.